Hakan Kayan

Hakan Kayan

Auto-generated profile, based on publicly available information

Hakan Kayan

Department of Emergency Medicine, Canakkale Onsekiz Mart University, Canakkale, Türkiye

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2026 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
MDMurat DAŞ
Murat DAŞ
ÖKÖzge Kurtlu
Özge Kurtlu
EÇEce ÜNAL Ünal Çetin
Ece ÜNAL Ünal Çetin
HKHakan Kayan
Hakan Kayan
SGSenem Guler
Senem Guler
YBYavuz Beyazit
Yavuz Beyazit
Mortality risk among patients admitted to the emergency department (ED) with acute upper gastrointestinal (GI) bleeding is heterogeneous, underscoring the importance of early identification of high-risk individuals. This study aimed to evaluate the prognostic performance of the prognostic nutritional index (PNI) in predicting 30-day mortality and to determine whether incorporating PNI into established risk markers enhances prognostic accuracy. In this retrospective cohort study, we analyzed data from 619 patients with acute upper GI bleeding who presented to a tertiary university hospital between January 1, 2018, and December 31, 2024. Demographic, clinical, and laboratory data were extracted from medical records. PNI was calculated using serum albumin and lymphocyte count at the time of admission, with the primary outcome being 30-day mortality. Predictors of mortality were examined using univariable and multivariable logistic regression analyses. The incremental prognostic value of PNI was evaluated through receiver operating characteristic (ROC) analysis and the DeLong test. The median age of participants was 74.0 years (interquartile range: 63.0-81.0), and 38% of the patients were female. The observed 30-day mortality rate was 7.9%. Non-survivors displayed significantly lower PNI levels compared to survivors (37.6 vs. 43.6; p < 0.001). In multivariable analysis, PNI (odds ratio [OR]: 0.847 [0.765-0.938]), lactate level (OR: 1.225 [1.047-1.434]), and the ABC score (OR: 1.201 [1.053-1.370]) were identified as independent predictors of mortality. The risk of mortality increased substantially when low PNI was combined with a high ABC score or elevated lactate level. Incorporating PNI into a baseline model resulted in a modest increase in the area under the receiver operating characteristic curve (AUROC) from 0.708 to 0.774 (p = 0.049). In conclusion, PNI serves as an independent predictor of 30-day mortality in patients with acute upper GI bleeding. Its integration with existing risk scores may enhance prognostic discrimination and facilitate early risk stratification in the ED.

27 October 2026 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
MDMurat DAŞ
Murat DAŞ
ÖKÖzge Kurtlu
Özge Kurtlu
EÇEce ÜNAL Ünal Çetin
Ece ÜNAL Ünal Çetin
HKHakan Kayan
Hakan Kayan
SGSenem Guler
Senem Guler
YBYavuz Beyazit
Yavuz Beyazit
Early mortality risk assessment is crucial for acute upper gastrointestinal bleeding (UGIB). This study sought to develop and internally validate a prediction model using age, pulse, urea, and albumin (APUA) components, and to assess the added value of admission lactate levels. This retrospective, single-center study included 700 adults presenting to the emergency department with suspected acute UGIB between 2018 and 2025, excluding confirmed variceal hemorrhage. We developed multivariable logistic regression models, both with and without lactate, using continuous APUA components to predict 30-day all-cause mortality. Complete-case analyses evaluated discrimination, calibration, and net benefit, with internal validation performed using 2,000 bootstrap resamples. Fifty-two patients (7.4%) died within 30 days. Lactate was independently associated with mortality (adjusted odds ratio per 1-mmol/L increase, 1.455; 95% confidence interval, 1.270–1.667). Adding lactate significantly increased the apparent area under the receiver operating characteristic curve (AUC) from 0.693 to 0.777 (AUC difference, 0.084; p = 0.003) and improved the optimism-corrected concordance statistic from 0.670 to 0.756. Calibration and overall predictive accuracy also improved, and decision curve analysis showed a higher net benefit across most evaluated thresholds. Furthermore, lactate enhanced the apparent discrimination of three established comparator scores. While the APUA-component model demonstrated modest discrimination, incorporating lactate significantly improved its predictive performance. Independent external validation is necessary before clinical implementation.